Outcomes Following Standardized Implantable Cardioverter-defibrillator Reprogramming

Multiple randomized controlled trials have demonstrated that programming implantable cardioverter-defibrillators (ICDs) with longer detection intervals and higher detection rates results in significant reductions in the delivery of inappropriate therapy without increasing the number of adverse event...

Descripción completa

Detalles Bibliográficos
Autores principales: Martini, Matthew, Kalscheur, Matthew, Dehn, Erin, McSherry, Teri, Leal, Miguel, Broman, Aimee, Kipp, Ryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MediaSphere Medical 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023023/
https://www.ncbi.nlm.nih.gov/pubmed/35474860
http://dx.doi.org/10.19102/icrm.2022.130403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023023/
https://www.ncbi.nlm.nih.gov/pubmed/35474860
http://dx.doi.org/10.19102/icrm.2022.130403

Ejemplares similares